MagSense FR Imaging

MagSense FR imaging targets folate receptors linked to ovarian cancer, offering the chance to detect disease earlier, when more treatment options are available.

Visit website

More from Imagion Biosystems, Inc

Delivery

MagSense HER2 Imaging Agent

MagSense HER2 imaging is designed to help clinicians see what ultrasound might miss — highlighting cancerous nodes with targeted precision. Imagion Biosystems is now preparing for Phase II clinical trials evaluating the MagSense HER2 imaging agent — designed to help detect the spread of HER2-positive breast cancer to regional lymph nodes without the need for invasive biopsies.

MagSense PSMA Imaging

MagSense PSMA imaging utilizes the same PSMA-specific targeting molecule as PET tracers but without the need for radiation, enabling MRI to non-invasively detect prostate cancer and guide precision biopsies.